TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases
Recruiting · NCT05948813 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| TY-9591 in the Patients With EGFR Mutations in Advanced NSCLC With Brain Metastases | Brain Metastases, Neoplasms by Site, brain disorder, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder, non-small cell lung carcinoma | Recruiting | Phase 2 | 2026-08-25 | NCT05948813 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| TYK Medicines, Inc | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Cancer Center/Cancer Hospitial,Chinese Academy of Medical Sciences and Peking Union Medical College | Beijing | China | 2 |